AU2002233166B2 - Synthetic vaccines comprising polyhydroxypolymer carriers - Google Patents
Synthetic vaccines comprising polyhydroxypolymer carriers Download PDFInfo
- Publication number
- AU2002233166B2 AU2002233166B2 AU2002233166A AU2002233166A AU2002233166B2 AU 2002233166 B2 AU2002233166 B2 AU 2002233166B2 AU 2002233166 A AU2002233166 A AU 2002233166A AU 2002233166 A AU2002233166 A AU 2002233166A AU 2002233166 B2 AU2002233166 B2 AU 2002233166B2
- Authority
- AU
- Australia
- Prior art keywords
- immunogen
- polyhydroxypolymer
- poly
- epitope
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0007—Nervous system antigens; Prions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6087—Polysaccharides; Lipopolysaccharides [LPS]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6093—Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/DK2001/000113 WO2001062284A2 (en) | 2000-02-21 | 2001-02-19 | Novel method for down-regulation of amyloid |
| AUPCT/DK2001/000113 | 2001-02-19 | ||
| US09/785,215 | 2001-02-20 | ||
| US09/785,215 US7135181B2 (en) | 2000-02-21 | 2001-02-20 | Method for down-regulation of amyloid |
| DKPA200101231 | 2001-08-20 | ||
| DKPA200101231 | 2001-08-20 | ||
| US33754301P | 2001-10-22 | 2001-10-22 | |
| US60/337,543 | 2001-10-22 | ||
| PCT/DK2002/000112 WO2002066056A2 (en) | 2001-02-19 | 2002-02-19 | Synthetic vaccines comprising polyhydroxypolymer carriers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2002233166A1 AU2002233166A1 (en) | 2003-02-27 |
| AU2002233166B2 true AU2002233166B2 (en) | 2006-06-29 |
Family
ID=35160895
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002233166A Ceased AU2002233166B2 (en) | 2001-02-19 | 2002-02-19 | Synthetic vaccines comprising polyhydroxypolymer carriers |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1363664A2 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2004529881A (cg-RX-API-DMAC10.html) |
| CN (1) | CN100562338C (cg-RX-API-DMAC10.html) |
| AU (1) | AU2002233166B2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA2440197A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL157475A0 (cg-RX-API-DMAC10.html) |
| NO (1) | NO335602B1 (cg-RX-API-DMAC10.html) |
| NZ (1) | NZ527720A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2002066056A2 (cg-RX-API-DMAC10.html) |
| ZA (1) | ZA200400895B (cg-RX-API-DMAC10.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004024183A1 (en) * | 2002-09-12 | 2004-03-25 | Pharmexa A/S | Immunization against autologous ghrelin |
| WO2005037190A2 (en) * | 2003-09-03 | 2005-04-28 | Dendritherapeutics, Inc. | Multiplex vaccines |
| WO2005046605A2 (en) * | 2003-11-07 | 2005-05-26 | University Of Rochester | Compositions and methods of treating neurological diseases |
| AU2012229234B2 (en) * | 2011-03-11 | 2016-02-25 | Flow Pharma Inc. | Vaccine formulation of mannose coated peptide particles |
| CN103665113A (zh) * | 2012-09-14 | 2014-03-26 | 深圳市安群生物工程有限公司 | 人Aβ42抗原决定簇多肽、抗原、抗体、用途及试剂盒 |
| RU2635517C1 (ru) * | 2016-09-14 | 2017-11-13 | Закрытое акционерное общество "Институт фармацевтических технологий" (ЗАО "ИФТ") | Синтетический иммуноген для защиты и лечения от зависимости от психоактивных веществ |
| CN112165956A (zh) * | 2018-04-10 | 2021-01-01 | Ac免疫有限公司 | 抗Aβ治疗性疫苗 |
| MA52180A (fr) | 2018-04-10 | 2021-02-17 | Ac Immune Sa | Vaccins thérapeutiques anti-abêta |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0625910B1 (en) * | 1992-02-11 | 2003-07-23 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Dual carrier immunogenic construct |
| AU4377793A (en) * | 1992-05-20 | 1993-12-13 | Johns Hopkins University, The | Alternative receptor therapy |
| KR100731820B1 (ko) * | 1998-10-05 | 2007-06-25 | 파멕사 에이/에스 | 치료적 백신화를 위한 새로운 방법 |
-
2002
- 2002-02-19 IL IL15747502A patent/IL157475A0/xx unknown
- 2002-02-19 NZ NZ527720A patent/NZ527720A/en unknown
- 2002-02-19 EP EP02700174A patent/EP1363664A2/en not_active Withdrawn
- 2002-02-19 AU AU2002233166A patent/AU2002233166B2/en not_active Ceased
- 2002-02-19 WO PCT/DK2002/000112 patent/WO2002066056A2/en not_active Ceased
- 2002-02-19 JP JP2002565614A patent/JP2004529881A/ja active Pending
- 2002-02-19 CA CA002440197A patent/CA2440197A1/en not_active Abandoned
- 2002-08-20 CN CNB028163265A patent/CN100562338C/zh not_active Expired - Fee Related
-
2004
- 2004-01-30 NO NO20040431A patent/NO335602B1/no not_active IP Right Cessation
- 2004-02-03 ZA ZA200400895A patent/ZA200400895B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2004529881A (ja) | 2004-09-30 |
| ZA200400895B (en) | 2005-05-03 |
| CN100562338C (zh) | 2009-11-25 |
| CA2440197A1 (en) | 2002-08-29 |
| NZ527720A (en) | 2005-03-24 |
| WO2002066056A2 (en) | 2002-08-29 |
| CN1893970A (zh) | 2007-01-10 |
| IL157475A0 (en) | 2004-03-28 |
| NO335602B1 (no) | 2015-01-12 |
| NO20040431L (no) | 2004-04-16 |
| WO2002066056A8 (en) | 2004-04-29 |
| EP1363664A2 (en) | 2003-11-26 |
| WO2002066056A3 (en) | 2003-01-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7097837B2 (en) | Synthetic vaccine agents | |
| JP4087898B2 (ja) | 免疫原性に乏しい抗原と合成ペプチド担体との結合体およびそれらからなるワクチン | |
| SK722002A3 (en) | Method for down-regulating GDF-8 activity | |
| RS51699B (sr) | Beta-amiloid-analog-t-ćelijski-epitop vakcina | |
| EP0191536B1 (en) | Synthetic immunogen | |
| US20040191264A1 (en) | Synthetic vaccine agents | |
| US20050049197A1 (en) | Induction of immune response against desired determinants | |
| WO2002034287A2 (en) | Therapeutic vaccine formulations containing chitosan | |
| de Velasco et al. | Synthetic peptides representing T-cell epitopes act as carriers in pneumococcal polysaccharide conjugate vaccines | |
| US20050063952A1 (en) | Immunogenic CEA | |
| AU2020204779B2 (en) | Vaccines targeting neoepitopes | |
| NZ527720A (en) | Synthetic vaccine agents | |
| AU2002233166A1 (en) | Synthetic vaccines comprising polyhydroxypolymer carriers | |
| US20040037840A1 (en) | Novel therapeutic vaccine formulations | |
| US20020172673A1 (en) | Method for down-regulating IgE | |
| Dakappagari et al. | Intracellular delivery of a novel multiepitope peptide vaccine by an amphipathic peptide carrier enhances cytotoxic T‐cell responses in HLA‐A* 201 mice | |
| EP2407178A2 (en) | Monovalent and polyvalent synthetic polysaccharide antigens for immunological intervention in disease | |
| EP1539232A1 (en) | Immunization against autologous ghrelin | |
| EP1888111A1 (en) | Modulation of cholesteryl ester transfer protein (cetp) activity | |
| US20080253993A1 (en) | Immunogenic Egfr Peptides Comprising Foreign T Cell Stimulating Epitope | |
| US20200289629A1 (en) | Toxoplasma gondii vaccines and their use | |
| KR102301961B1 (ko) | 아밀로이드 접합체 및 그의 용도 및 방법 | |
| US20220332770A1 (en) | High-Density Flagellin-Displaying Virus-Like Particle As Vaccine Carrier | |
| WO2024226106A1 (en) | Tp0751 chimera-containing vaccine | |
| HK1130687A (en) | Monovalent and polyvalent synthetic polysaccharide antigens for immunological intervention in disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |